The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โABBVโ.
According to AbbVie's latest financial reports the company's current earnings are ยฃ62.81 Billion. In 2025 the company made an earning of ยฃ4.93 Billion, an increase over its 2024 earnings that were of ยฃ2.77 Billion. The earnings displayed on this page is the company's Pretax Income.